期刊文献+

围麻醉期影响肿瘤转移和复发的研究进展 被引量:5

Research advances of perianesthesia on tumor metastasis and recurrence
原文传递
导出
摘要 背景 肿瘤的高发病率和高病死率给医学带来了巨大的挑战,肿瘤切除术是肿瘤治疗的主要手段之一,但研究表明麻醉药物和技术可影响肿瘤术后复发与转移。 目的 阐述麻醉药物、技术对术后肿瘤转移及复发的影响,为临床麻醉策略提供参考。 内容 肿瘤的发生发展与免疫系统监控有着密切联系,重点讨论麻醉药物以及技术通过促进或抑制免疫系统以及介导信号转导通路参与炎症、肿瘤转移复发等病理过程。 趋向 大样本多中心随机对照试验为阐明麻醉与肿瘤术后转移及复发的关系提供更多的证据,这些证据是提高肿瘤患者生存率的关键。 Background Excision surgery provides a chance of cure for patients with cancer, but most cancer-related deaths in patients who have received previous surgical treatment are caused by metastatic diseases. Recent research suggests that a few anesthetic agents or procedures can influence pathophysiology of metastasis in the postoperative period. Objective This review summarizes the evidence for an impact of anesthesia agents on patient outcome after cancer surgery, which provides effective anesthesia strategy. Content The development of tumor is closely related to the immune system monitoring. This review describes tumor immunity and the effects of various anesthetic agents and anesthesia techniques on tumor recurrence after surgery. Trend Only randomized, clinical trials can provide us with conclusive reports about the link between anesthesia and tumor recurrence, which is the key in improving surviving rate of cancer patients.
作者 郭玉 王嘉锋 邓小明 Guo Ya;Wang Jiqfeng;Deng Xiaoming(Faculty of Anesthesialogy, Changhai Hospital, Naval Medical University, Shanghai 200433, Chin)
出处 《国际麻醉学与复苏杂志》 CAS 2018年第5期484-486,共3页 International Journal of Anesthesiology and Resuscitation
关键词 围麻醉期 肿瘤转移 复发 Perianesthesia Tumor metastasis Relapse
  • 相关文献

参考文献2

二级参考文献47

  • 1康培良,黄文,王继德.胰腺癌患者围手术期T细胞亚群和NK细胞活性的动态观察[J].中国肿瘤临床与康复,2005,12(2):103-105. 被引量:7
  • 2Fink T, Ebbesen P, Koppelhusy U. Natural killer cell-mediated basal and interferon -enhanced cytotoxicity against liver cancer cells is significantly impaired under in vivo oxygen conditions. Scand J Immunol, 2003, 58(6): 607-612.
  • 3Conishi T , Ohishi Y, Imagawa K, et al. An assessment of the immunological environment based on intratumoral cytokine production in renal cell arcinoma. BJU Int, 1999, 83 (4): 488-492.
  • 4Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic efector Th 17 and regulatory T cells. Nature, 2006, 441 (7090): 235 -238.
  • 5Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self -tolerance and autoimmune disease, Immunol Rev, 2006, 212 (1 ): 8 -27.
  • 6Hiura T, Kagamu H, Miura S, et al. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression. J Immunol, 2005, 175 (8): 5058- 5066.
  • 7Ohira M, Ohdan H, Mitsuta H, et al. Adoptive transfer of TRAIL?expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy. Transplantation, 2006, 82 (12): 1712.
  • 8Wada H, Seki S, Takahashi T, et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving Th1/Th2 Cytokine Balance.Anesthesiology,2007,106(3):499-506.
  • 9Landen CN Jr , Lin YG, Armaiz Pena GN, et al. Neuroendocrine modulation of signal transducer and activator of transcription -3 in ovarian cancer. Cancer Res, 2007, 67(21): 10389-10396.
  • 10Goldfarb Y, Ben -Eliyahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Dis, 2006, 26(2): 99-114.

共引文献12

同被引文献40

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部